Bob Rai - Avricore Health CEO, Director
| AVCR Stock | CAD 0.15 0.01 6.25% |
CEO
Mr. Bob Rai serves as Chief Executive Officer, Director of Vanc Pharmaceuticals Inc. Mr. Rai is a graduate of the University of British Columbia with BS Degrees in Biochemistry and Pharmaceutical Science. Mr. Rai recently operated a chain of The Medicine Shoppe Pharmacies in Greater Vancouver for the past 21 years, he has had several successful entrepreneurial and charitable endeavors. In 1998 Mr. Rai and his partners pioneered and revolutionized the online pharmacy business to the United States. The online sales and distribution of prescription medicines saw unprecedented industry growth and as other operators followed suit, the unique business concept became a billion dollar industry across Canada since 2017.
| Tenure | 7 years |
| Address | 789 West Pender Street, Vancouver, BC, Canada, V6C 1H2 |
| Phone | 604-773-8943 |
| Web | https://avricore.com |
Avricore Health Management Efficiency
The company has return on total asset (ROA) of (0.2277) % which means that it has lost $0.2277 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5653) %, meaning that it generated substantial loss on money invested by shareholders. Avricore Health's management efficiency ratios could be used to measure how well Avricore Health manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.39 in 2024. Return On Capital Employed is likely to drop to -0.39 in 2024. At this time, Avricore Health's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 1.4 M in 2024, despite the fact that Non Currrent Assets Other are likely to grow to (972.9 K).Similar Executives
| Found 3 records | CEO Age | ||
| Kara Raiguel | Berkshire Hathaway CDR | N/A | |
| Peter Eastwood | Berkshire Hathaway CDR | N/A | |
| Andrew Jassy | Amazon CDR | 56 | |
Management Performance
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.23 |
Avricore Health Leadership Team
Elected by the shareholders, the Avricore Health's board of directors comprises two types of representatives: Avricore Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avricore. The board's role is to monitor Avricore Health's management team and ensure that shareholders' interests are well served. Avricore Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avricore Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Sindelar, Director | ||
| Kevin Strong, CFO | ||
| Rodger Seccombe, Head Director | ||
| Deena Siblock, Corporate Secretary | ||
| Sherif Guorgui, Director | ||
| Bob Rai, CEO, Director | ||
| David Hall, Chairman of the Board | ||
| Hector Bremner, CEO Director | ||
| Will Seccombe, Communications Advisor | ||
| CPA CFO, CFO Sec | ||
| Alan Arnstein, Director | ||
| Allan Shapiro, Mang Devel |
Avricore Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avricore Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.57 | ||||
| Return On Asset | -0.23 | ||||
| Profit Margin | (0.32) % | ||||
| Operating Margin | (0.28) % | ||||
| Current Valuation | 14.59 M | ||||
| Shares Outstanding | 99.64 M | ||||
| Shares Owned By Insiders | 9.68 % | ||||
| Number Of Shares Shorted | 25.09 K | ||||
| Price To Book | 7.45 X | ||||
| Price To Sales | 4.33 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Avricore Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Avricore Health's short interest history, or implied volatility extrapolated from Avricore Health options trading.
Pair Trading with Avricore Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Avricore Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avricore Health will appreciate offsetting losses from the drop in the long position's value.Moving against Avricore Stock
| 0.54 | BRK | Berkshire Hathaway CDR | PairCorr |
| 0.49 | MSFT | Microsoft Corp CDR | PairCorr |
| 0.44 | META | Meta Platforms CDR | PairCorr |
The ability to find closely correlated positions to Avricore Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Avricore Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Avricore Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Avricore Health to buy it.
The correlation of Avricore Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avricore Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avricore Health moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Avricore Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avricore Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. Note that the Avricore Health information on this page should be used as a complementary analysis to other Avricore Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Avricore Stock analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |